Blair Lucas - TBG Diagnostics Insider

TBG Diagnostics Limited -- Australia Stock  

 0.16  0.00  0.00%

Company Secretary

Mr. Blair Lucas was Company Secretary of Progen Pharmaceuticals Ltd since August 21 2012
  Executive Since 2012      
61 7 3273 9133  http://www.tbgbio.com
Lucas serves as Company Secretary and inhouse counsel for a number of private and public companies in both China and Australia. He has knowledge of Australian corporate regulatory environment and practical experience in China, including various capital raisings, crossborder transactions, and corporate and commercial law. He holds Master of Law, a Bachelor of Arts in Chinese and is a Member of Chartered Secretaries Australia.

Management Efficiency

The company has return on total asset (ROA) of (47.62) % which means that it has lost $47.62 on every $100 spent on asset. This is way below average.

Similar Executives

Entity Summary

TBG Diagnostics Limited, a biotechnology company, focuses on the development, manufacture, and marketing of nucleic acid test kits. TBG Diagnostics Limited (PGL) is traded on Australian Securities Exchange in Australia. It is located in Darra, QLD and employs 10 people.

Did you try this?

Run Portfolio Diagnostics Now
   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
Hide  View All  Next  Launch Portfolio Diagnostics
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add TBG Diagnostics Limited to your portfolio

Top Management

TBG Diagnostics Limited Leadership Team
Keith Dredge, Director, Ph.D
YuZen Cheng, Director
Lee Horobin, Executive, CPA
Generosa Hipona, Executive
Blair Lucas, Executive
Hongjen Chang, Director
Fleur Lankesheer, Director
Leslie Tillack, CEO
ChiaChuan Chang, Director
ShiChung Chang, Director, Ph.D
Indrajit Arulampalam, Chairman
Emily Lee, Director
Christopher Harvey, Director

Stock Performance

TBG Diagnostics Performance Indicators